For weight management , NICE technology appraisal guidance supports semaglutide 2.4 mg (Wegovy) for adults with at least one weight-related comorbidity and a BMI 35 kg/m (or 30 kg/m in exceptional circumstances), as part of a specialist weight management service
Impact on Early Treatment Decisions As these oral GLP-1 therapies become easier to use, clinicians are reconsidering when to start treatment
Services produces measurable results
LoCITT is dedicated to accelerating discoveries for the complex, multisystem condition which has affected the lives of more than 400 million people worldwide
Peptides are inherently fragile, prone to falling apart when exposed to heat, light or improper handling
21Y71, 19Y89), the Faculty Development Grants from Hubei University of Medicine (2018QDJZR04), and Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine) (Grant No